We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Mind Medicine Mindmed Inc
51 own
81 watching
Current Price
$7.32
$0.24
(3.39%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
339.81M
52-Week High
12.22000
52-Week Low
3.49000
Average Volume
0.44M
Dividend Yield
--
P/E Ratio
--
Market Capitalization339.81M52-Week High12.2200052-Week Low3.49000Average Volume0.44MDividend Yield--P/E Ratio--What does the Mind Medicine Mindmed Inc do?
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
Read More
How much money does Mind Medicine Mindmed Inc make?
News & Events about Mind Medicine Mindmed Inc.
Zolmax
1 year ago
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD Free Report) CEO Robert Barrow sold 15,502 shares of the businesss stock in a transaction dated Tuesday, June 27th. The shares were sold at an average price of $3.20, for a total transaction of $49,606.40. Following the completion of the sale...
Zolmax
1 year ago
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD Free Report) CFO Schond L. Greenway sold 11,635 shares of the stock in a transaction that occurred on Tuesday, June 27th. The stock was sold at an average price of $3.20, for a total transaction of $37,232.00. Following the completion of the ...
Ticker Report
1 year ago
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD Free Report) CEO Robert Barrow sold 15,502 shares of the businesss stock in a transaction dated Tuesday, June 27th. The shares were sold at an average price of $3.20, for a total transaction of $49,606.40. Following the completion of the sale...
Globe Newswire
1 year ago
FCM Won the Majority of Retail Shareholders Vote and Thanks Them for Their Strong Support FCM Exhorts Institutions to Live Up to Touted Social Investment Goals and Closely Monitor MindMed Board and Management FCM Concerned MindMed Board and Management Will Continue Decimation of Shareholder Value ...
Business Wire
1 year ago
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Companys management team will participate in the H.C. Wainwright...
Frequently Asked Questions
Frequently Asked Questions
What is Mind Medicine Mindmed Inc share price today?
Can Indians buy Mind Medicine Mindmed Inc shares?
How can I buy Mind Medicine Mindmed Inc shares from India?
Can Fractional shares of Mind Medicine Mindmed Inc be purchased?
What are the documents required to start investing in Mind Medicine Mindmed Inc stocks?
What is today’s traded volume of Mind Medicine Mindmed Inc?
What is today’s market capitalisation of Mind Medicine Mindmed Inc?
What is the 52-Week High and Low Range of Mind Medicine Mindmed Inc?
What percentage is Mind Medicine Mindmed Inc down from its 52-Week High?
What percentage is Mind Medicine Mindmed Inc up from its 52-Week Low?
Current Price
$7.32
$0.24
(3.39%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.